Eric Liebler - Electrocore LLC Senior Vice President - Neurology

ECOR Stock  USD 9.92  0.02  0.20%   

President

Mr.Eric J Liebler is Senior Vice President Neurology of company.Eric brings more than 20 years of neurological industry and association experience to electroCore. In 2009, he cofounded Nautilus Neurosciences, a neurologyfocused specialty pharmaceutical company focused on identifying and developing drugs benefiting those affected by neurological disorders, and brought to market Cambia for the treatment of acute migraine. At Nautilus, Eric was involved in all facets of the companys organization and early success, including initial funding, product commercialization, and sales and marketing. Eric has held leadership positions at Elan, Amarin, Enzon Pharmaceuticals, Questcor Pharmaceuticals, and Pharmacopeia. He founded Nisola LLC, an advocacy and business strategy consulting firm focused on serving clients in the field of neurology, and sat on the Board of Trustees of the American Academy of Neurology Foundation for more than a decade. Eric began his career at Athena Neurosciences, a pioneer in the development of neurology drugs, after graduating with honors from Tufts University.
Age 60
Address 200 Forge Way, Rockaway, NJ, United States, 07866
Phone973 290 0097
Webhttps://www.electrocore.com

Electrocore LLC Management Efficiency

The company has return on total asset (ROA) of (0.4918) % which means that it has lost $0.4918 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5349) %, meaning that it created substantial loss on money invested by shareholders. Electrocore LLC's management efficiency ratios could be used to measure how well Electrocore LLC manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/22/2024, Return On Tangible Assets is likely to drop to -1.23. In addition to that, Return On Capital Employed is likely to grow to -2.24. At this time, Electrocore LLC's Asset Turnover is relatively stable compared to the past year.
Electrocore LLC currently holds 626 K in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Electrocore LLC has a current ratio of 5.06, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Electrocore LLC's use of debt, we should always consider it together with its cash and equity.
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation therapies. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey. Electrocore operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 52 people. Electrocore LLC (ECOR) is traded on NASDAQ Exchange in USA. It is located in 200 Forge Way, Rockaway, NJ, United States, 07866 and employs 68 people. Electrocore LLC is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Electrocore LLC Leadership Team

Elected by the shareholders, the Electrocore LLC's board of directors comprises two types of representatives: Electrocore LLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Electrocore. The board's role is to monitor Electrocore LLC's management team and ensure that shareholders' interests are well served. Electrocore LLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Electrocore LLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
Joshua Lev, Chief Officer
Jackie Dorsky, VP Marketing
Manuel Marques, Senior Operations
Joseph Errico, Chairman of the Board, Co-Founder, Principal Investor and Chief Science & Strategy Officer
Carrie Kochek, Senior Resources
Donald Melnikoff, Regulatory Engineering
Michael Mansfield, Vice Marketing
MD MBA, Chief Officer
Amanda Yanuklis, Chief Staff
Brian Posner, CFO Sec
Mitch Deshon, Vice Development
Daniel Goldberger, CEO Director
Michael Romaniw, Executive Operations
Thomas MD, Independent Founder
Iain Strickland, VP Strategy
Eric Liebler, Senior Vice President - Neurology

Electrocore Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Electrocore LLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Electrocore LLC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Electrocore LLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electrocore LLC will appreciate offsetting losses from the drop in the long position's value.

Moving against Electrocore Stock

  0.86IDXX IDEXX LaboratoriesPairCorr
  0.84AGL agilon healthPairCorr
  0.83TFX Teleflex IncorporatedPairCorr
  0.81GCTK GlucoTrackPairCorr
  0.79ELAB Elevai Labs, CommonPairCorr
The ability to find closely correlated positions to Electrocore LLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Electrocore LLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Electrocore LLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Electrocore LLC to buy it.
The correlation of Electrocore LLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Electrocore LLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Electrocore LLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Electrocore LLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Electrocore Stock Analysis

When running Electrocore LLC's price analysis, check to measure Electrocore LLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electrocore LLC is operating at the current time. Most of Electrocore LLC's value examination focuses on studying past and present price action to predict the probability of Electrocore LLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electrocore LLC's price. Additionally, you may evaluate how the addition of Electrocore LLC to your portfolios can decrease your overall portfolio volatility.